Solifenacin Succinate — CAS 242478-38-2

Solifenacin Succinate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Mediocon Inc manufactures GMP-compliant Solifenacin Succinate API at its Aurangabad facility to international pharmacopoeial standards.

• Overactive bladder (OAB) treatment
• Urge urinary incontinence
• Urinary urgency and frequency
• Detrusor overactivity

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support